对于C-糖化的 Zweifel 烯化
Florian Trauner1,2, Bilel Boutet1, Fabian Pilz2
1Technische Universität Darmstadt, Clemens-Schöpf-Institut für Organische Chemie und Biochemie, Peter-Grünberg-Straße 4, 64287, Darmstadt, Germany.
Communications chemistry
|December 21, 2024
概括
在糖基衍生物上使用Zweifel的olefination来提升C-glycoside的合成. 这种方法有效地为稳定,生物可利用的候选药物如gliflozins创建碳-碳键.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 碳水化合物化学 碳水化合物化学
背景情况:
- 在药物开发中,C-糖化物比O-糖化物提供了更高的稳定性和生物可用性,这对于药物开发至关重要.
- 它们的治疗潜力跨越了糖尿病和癌症等疾病.
- 有效合成C-糖酸键仍然是一个关键的挑战.
研究的目的:
- 开发一种选择性和高效的合成C-糖化的方法.
- 为了探索Zweifel的olefination在C-glycoside合成中的应用.
- 为了获得新型的基甲基,基甲基和基甲基-C-糖化物.
主要方法:
- 使用甘氨酸衍生物作为起始材料.
- 采用D-glucal,L-rhamnal,D-xylal和L-arabinal支架的α-化. 这种支架使用了D-glucal,L-rhamnal,D-xylal和L-arabinal支架的α-化.
- 应用Zweifel炼反应用于C-C键的形成.
主要成果:
- 展示了一种简单的合成不和C-糖酸的策略.
- 成功合成了,异和基-C-糖化物.
- 提供了与药物相关的gliflozins和新型rhamnal-和xylal-analogs的使用权.
结论:
- 采用Zweifel的油性化提供了一种优雅而有选择的C-糖化物的途径.
- 这种方法有助于合成潜在的有价值的治疗药物.
- 该方法适用于各种糖基支架,扩大合成可能性.
相关概念视频
Oligosaccharide Assembly
2.8K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
2.8K
Protein Folding Quality Check in the RER
3.7K
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
3.7K
Protein Glycosylation
6.8K
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Glycosylation occurs in...
6.8K
Protein Modifications in the RER
5.0K
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
5.0K
Proteoglycans
3.9K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.9K
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
167
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
167


